[ad_1]
What is herd immunity and could it work with COVID-19?
Herd immunity is when a virus can no longer spread easily because enough people are immune to it. That lowers the chances of the virus jumping from person to person and reaching those who haven’t been infected yet.
People can become immune to certain viruses after surviving infection or being vaccinated. Typically, at least 70% of a population must be immune to achieve herd immunity. But how long immunity lasts varies depending on the virus, and it’s not yet known how long COVID-19 survivors might have that protection.
How easily the virus spreads also plays a key role.
Say, for example, someone who’s infected with a particular virus typically transmits it to two others. The chances of that person passing it on to others would be lower if half the population is already immune, said Dr. Walter Orenstein, a vaccine expert at Emory University.
The odds of transmission fall further if even more of the population is immune. That could cause new infections to die out.
But if a virus is more infectious, a higher percentage of people would need to have immunity to stop the spread and achieve herd immunity, Orenstein said.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Citation:
What is herd immunity and could it work with COVID-19? (2020, June 9)
retrieved 9 June 2020
from https://medicalxpress.com/news/2020-06-herd-immunity-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
